Prognostic Value of Extramural Depth of Tumor Invasion to Thickness of Mesorectum Ratio at Pretreatment Endorectal Ultrasound in T3 Rectal Cancer Patients
- PMID: 40784817
- DOI: 10.1016/j.ultrasmedbio.2025.07.006
Prognostic Value of Extramural Depth of Tumor Invasion to Thickness of Mesorectum Ratio at Pretreatment Endorectal Ultrasound in T3 Rectal Cancer Patients
Abstract
Objective: To evaluate the prognostic value of the extramural depth (EMD)/thickness of mesorectum (TM) ratio in patients with cT3 rectal cancer (RC).
Methods: This study enrolled 382 treatment-naive cT3 RC patients undergoing endorectal ultrasound from January 2018 to January 2020. The last follow-up date was January 31, 2025. The EMD/TM ratio was calculated. T3 substages (T3a-c) were classified using 5-mm/10-mm EMD cutoffs. Survival analysis employed Kaplan-Meier and Cox regression. Predictive performance was evaluated via the Akaike Information Criterion (AIC) and time-dependent area under the curve (AUC).
Results: The optimal cutoff value for the EMD/TM ratio was 0.3 based on ROC analysis. Patients with an EMD/TM ratio >0.3 had significantly lower 5-y PFS and OS rates (PFS: 60.45% vs. 77.63%, OS: 74.14% vs. 92.92%, both p < 0.001) compared to those with a ratio ≤0.3. A significant difference in 5-y OS was observed among the T3 subgroups (p = 0.004), but there was no significant difference in 5-y PFS (p = 0.180). Multivariable analysis indicated that the EMD/TM ratio was an independent predictor of PFS (HR: 2.91, 95% CI: 1.41-6.00, p = 0.018) and OS (HR: 2.91, 95% CI: 1.41-6.00; p = 0.004). Furthermore, high- and low-risk subpopulations of T3a RC were identified using the EMD/TM ratio and demonstrated distinctive 5-y PFS and OS (PFS: 62.43% vs. 77.20%, p = 0.006; OS: 80.95% vs. 92.80%, p = 0.008). The EMD/TM ratio showed superior predictive performance, with a lower AIC and better time-independent AUC than the T3 substage.
Conclusion: The EMD/TM ratio outperforms T3 substage in prognostic stratification for cT3 RC patients, offering a practical tool for clinical risk assessment.
Keywords: Endorectal ultrasound; Extramural depth; Rectal cancer; T3; Thickness of mesorectum.
Copyright © 2025 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.
Similar articles
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
-
Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.Eur J Oral Implantol. 2009 Winter;2(4):247-66. Eur J Oral Implantol. 2009. PMID: 20467602
-
Bisphosphonates in multiple myeloma: an updated network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 18;12(12):CD003188. doi: 10.1002/14651858.CD003188.pub4. Cochrane Database Syst Rev. 2017. PMID: 29253322 Free PMC article.
-
Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003875. doi: 10.1002/14651858.CD003875.pub3. Cochrane Database Syst Rev. 2009. PMID: 19821315 Free PMC article.
-
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2. Cochrane Database Syst Rev. 2017. PMID: 28901021 Free PMC article.
LinkOut - more resources
Full Text Sources